Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Caroline Dorsa | F | 64 | 14 years | |
| Stephen Sherwin | M | 75 | 14 years | |
| Eric Rowinsky | M | 67 | 14 years | |
| Michael Dambach | M | 57 | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert A. Hamm | M | 72 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 16 years |
| Stelios Papadopoulos | M | 75 | 15 years | |
| James Mullen | M | 65 | 21 years | |
| William Young | M | 79 | 11 years | |
| William Rastetter | M | 76 | 19 years | |
| Gina Consylman | F | 52 | 3 years | |
| Samantha Truex | F | - | 8 years | |
| George Scangos | M | 76 | 7 years | |
| Peter Kellogg | M | 67 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 7 years |
| Hans-Peter Hasler | M | 68 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 8 years |
| Lynne Sullivan | F | 58 | 10 years | |
| Lawrence C. Best | M | 75 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
| Alexander Denner | M | 54 | 14 years | |
| Phillip Sharp | M | 79 | 31 years | |
| Brian Posner | M | 62 | 14 years | |
| Nancy L. Leaming | F | 76 | 14 years | |
| Joseph Mara | M | 49 | - | |
| Eric S. Hoffman | M | 54 | 5 years | |
| Richard Mulligan | M | 69 | 14 years | |
| Alessandra Cesano | M | 63 | 2 years | |
| Akshay Vaishnaw | M | 61 | 7 years | |
| Maiken Keson-Brookes | F | 52 | 5 years | |
| Michael Panzara | M | 57 | 8 years | |
| Michael LaBarre | M | 60 | 3 years | |
| John Cox | M | 61 | 14 years | |
| Scott Anthony Climes | M | 59 | 2 years | |
| Robert Gagnon | M | 49 | 7 years | |
| Allen Kamer | M | 53 | 3 years | |
| Francesco Granata | M | 73 | 1 years | |
| Michael E. Markels | M | - | 1 years | |
| A. Sanders | F | 60 | 6 years | |
| Eric W. Kimble | M | 58 | 5 years | |
| John McCabe | M | 55 | 2 years | |
| Thomas F. Keller | M | 92 | - | |
| Richard Francis | M | 55 | 8 years | |
| Johny Humaloja | M | 58 | 5 years | |
| Cecilia Jones | F | 49 | - | |
| Susie Melody | F | - | 2 years | |
| Mark Bodenrader | M | 51 | - | |
| Steve Doares | M | - | 10 years | |
| Michael Pollock | M | - | 2 years | |
| Joseph J. Kenny | M | - | 5 years | |
| Jason Tardio | M | 47 | 9 years | |
| Robin A. Walker | M | 55 | 8 years | |
| Dell Faulkingham | M | 51 | 9 years | |
| Ben Harshbarger | M | 55 | 5 years | |
| Mary DiBiase | M | 63 | 16 years | |
| Liisa I. Nogelo | F | 53 | 11 years | |
| Marc Schegerin | M | 48 | 4 years | |
| Gisele Dion | F | 57 | 9 years | |
| Christopher Watt | M | 59 | 11 years | |
| William Mccarthy | M | - | 1 years | |
| Diego Cadavid | M | 58 | 8 years | |
| Daniel Char | M | 63 | 11 years | |
| Pratik Multani | M | 57 | 5 years | |
| Michael MacLean | M | 58 | 4 years | |
| Dinah Sah | M | 63 | 6 years | |
| Tony Kingsley | M | 60 | 6 years | |
| William R. Rohn | M | 80 | 2 years | |
| Alan B. Glassberg | M | 87 | 12 years | |
| Steven Holtzman | M | 70 | 5 years | |
| Raymond Pawlicki | M | 63 | 6 years | |
| Gregory Gorgas | M | 61 | 11 years | |
| Philip Gotwals | M | 61 | 2 years | |
| Arturo Molina | M | 65 | 4 years | |
| Stephen Tulipano | M | 65 | 8 years | |
| Alan Belzer | M | 91 | 10 years | |
| Matthew Onaitis | M | 53 | - | |
| Faheem Hasnain | M | 65 | 4 years | |
| John F. Weidenbruch | M | 63 | 5 years | |
| Michael D. Kowolenko | M | 68 | - | |
| Carol Gallagher | M | 59 | 1 years | |
| Anne Cook | F | 62 | 13 years | |
| Michael Gilman | M | 69 | 6 years | |
| Bruce R. Ross | M | 83 | 13 years | |
| Mary L. Good | M | 93 | 10 years | |
| Robert Peach | M | 68 | 2 years | |
| Robert L. de Jager | M | 82 | - | |
| Cary Pfeffer | M | 61 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 years |
| Mona L. Haynes | F | 66 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
| Melissa Morandi | F | 59 | 2 years | |
| Elizabeth Woo | F | 57 | 12 years | |
| Katherine J. Turner | M | 70 | 4 years | |
| Jeff Krstich | M | 74 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
| Connie Matsui | F | 70 | 18 years | |
| David Parkinson | M | 73 | 1 years | |
| Burt Adelman | M | 71 | 16 years | |
| Douglas Williams | M | 66 | 4 years | |
| David Hallal | M | 57 | 2 years | |
| Glenn F. Pierce | M | 68 | 5 years | |
| Cecil B. Pickett | M | 78 | 3 years | |
| Sylvie Grégoire | M | 62 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 years |
| Michael Lytton | M | 67 | 2 years | |
| Marijn Dekkers | M | 65 | 2 years | |
| John Dunn | M | 72 | 9 years | |
| David W Miller | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Craig Eric Schneier
- Personal Network
